We proudly celebrate our 23rd birthday, celebrating innovation, collaboration and scientific excellence that Pharmidex has helped create!
May 19, 2025
Since 2002,
Pharmidex has grown into a trusted partner in preclinical drug discovery and development, contributing to over 16,000 studies across therapeutic areas including CNS, immunology, oncology, respiratory and stroke.
We’re proud to be AAALAC- and MHRA-accredited, providing high-quality GLP and GCP-compliant services that have supported clients across biotech, pharma, and academia worldwide.
Our integrated expertise in Clinical Pathology, DMPK, ADMET, Pharmacokinetics, Toxicology and BBB penetration studies continues to shape the success of early-stage drug candidates.
💡 As we commemorate this milestone, we reflect on:
✔ The dedication of our exceptional team
✔ The trust and collaboration of our partners and clients
✔ Our continued mission to advance science and improve lives
Here’s to 23 years of impact and many more to come!
#Pharmidex23 #DrugDiscovery #PharmaceuticalInnovation #CRO #DMPK #OncologyResearch #CNS #PreclinicalResearch #TeamPharmidex
As we step into 2026, we’re proud to continue supporting our clients with local UK expertise delivered at an international scale. At Pharmidex , we support programmes from discovery through to IND-enabling studies, helping teams progress confidently from concept to clinic. With integrated in vivo, bioanalysis and translational capabilities, everything is delivered under one roof in the UK, ensuring quality, continuity and efficiency at every stage. 2025 was one of the most challenging years our industry has faced, yet together we continued to deliver meaningful science, supporting nearly 1,000 projects and contributing to medicines that make a real difference to patients’ lives. Thank you to our clients and partners for your continued trust. We look forward to supporting innovation and high-quality science in the year ahead.
As we come to the end of the year, we would like to wish everyone a very Happy Christmas and a healthy, successful New Year. 2025 has been a hugely rewarding year for the Pharmidex team. We’re proud to have supported close to 1,000 projects, working alongside innovative companies across pharma and biotech to help advance new ideas, technologies, and programmes. Thank you to our clients, collaborators, and partners for trusting us to be part of your journey. We look forward to continuing to support even more projects and working together in the year ahead. From everyone at Pharmidex , Merry Christmas and see you in the New Year! 🎄✨
We are pleased to share that Ian Knowles and Martin Barrett will attend Pharmacology 2025, organized by The British Pharmacological Society (BPS), at the ICC Belfast from 16–18 December 2025. They will host a Pharmidex exhibition stand, showcasing our key services and their importance in drug discovery and development. Ian and Martin will be delighted to meet attendees, exchange ideas, and explore new collaboration opportunities. Come and say hello!
